Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Natus Medical Inc : Natus Medical to Hold 2012 First Quarter Financial Results Conference Call on April 26

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/17/2012 | 01:05pm CET

Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company intends to release its 2012 first quarter financial results before the market opens on Thursday, April 26, 2012. Natus management will host an investment-community conference call the same day beginning at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) to discuss those results and to answer questions.

Individuals interested in listening to the conference call may do so by dialing 888-268-4176 for domestic callers, or 1-617-597-5493 for international callers, and entering reservation code 32875965. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 888-286-8010 for domestic callers, or 1-617-801-6888 for international callers, and entering reservation code 56980616.

The conference call also will be available real-time via the Internet at http://investor.natus.com, and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.

About Natus Medical Incorporated

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories.

Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, 650-802-0400
InvestorRelations@Natus.com
Vice President and Chief Financial Officer


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NATUS MEDICAL INC
11/11 Natus to Present at 28th Annual Piper Jaffray Healthcare Conference
11/03 NATUS MEDICAL : Management's Discussion and Analysis of Financial Condition and ..
10/28 BUYINS.NET : BABY, FCCO, ADC, CNBKA, OLBK, Expected to Trade Higher After Bullis..
10/20 NATUS MEDICAL INCORPORATED (NASDAQ : BABY) Files An 8-K
10/19 NATUS MEDICAL : beats 3Q profit forecasts
10/19 NATUS MEDICAL INC : Results of Operations and Financial Condition, Financial Sta..
10/19 Natus Medical Announces Third Quarter 2016 Financial Results
10/07 NATUS MEDICAL : Technology and Vestibular Function
10/05 Natus Medical to Hold 2016 Third Quarter Financial Results Conference Call on..
09/27 NATUS MEDICAL : Enters into Agreement to Acquire GN Otometrics; Provides Q3 Reve..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12/02 Deals scuppered by U.S. regulatory scrutiny
11/29 European spin-offs and carve-outs
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
11/15 Exclusive - EU regulators seen clearing $25 billion Abbott, St Jude deal
11/02DJU.S. HOT STOCKS : Hot Stocks to Watch
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
10/28 INSIDERINSIGHTS.COM DAILY ROUND UP 1 : Adc, erc, fsd
10/19 Natus Medical's (BABY) CEO Jim Hawkins on Q3 2016 Results - Earnings Call Tra..
10/19 Natus Medical Q3 revenues off 4%; earnings up 21% in Q3; updates guidance
10/19 Natus Medical beats by $0.05, beats on revenue
10/18 Notable earnings before Wednesday?s open
Advertisement
Financials ($)
Sales 2016 382 M
EBIT 2016 66,3 M
Net income 2016 48,2 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 25,40
P/E ratio 2017 23,08
Capi. / Sales 2016 3,19x
Capi. / Sales 2017 2,85x
Capitalization 1 218 M
More Financials
Chart NATUS MEDICAL INC
Duration : Period :
Natus Medical Inc Technical Analysis Chart | BABY | US6390501038 | 4-Traders
Full-screen chart
Technical analysis trends NATUS MEDICAL INC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 49,7 $
Spread / Average Target 34%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
James B. Hawkins President, Chief Executive Officer & Director
Robert A. Gunst Chairman
Jonathan A. Kennedy Chief Financial Officer, EVP & IR Contact
D. Christopher Chung VP-Medical Affairs, Quality & Regulatory
Doris E. Engibous Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NATUS MEDICAL INC-17.07%1 218
THERMO FISHER SCIENTIF..-1.23%56 058
DANAHER CORPORATION9.60%53 482
BOSTON SCIENTIFIC CORP..10.95%27 710
PHILIPS15.05%26 897
INTUITIVE SURGICAL, IN..16.57%24 668
More Results